Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia.

JCO Precis Oncol · 2021 · PMC8140802 · PMID 34036230

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

indeterminate significanceno p-value reported

Appendix Supplementary Methods: Panel Design and Processing The panel is generally ordered for one of the following conditions: acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), cytopenia, clonal cytopenia of undetermined significance, clonal hematopoiesis of indeterminate significance, myeloproliferative neoplasm, or other myeloid disorders.

also in 137 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.